Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polyomavirus BK Nephropathy After Renal Transplantation: Randomized Clinical Trial to Demonstrate That Switching to mTOR Inhibitor is More Effective Than a Reduction of Immunosuppressive Therapy

NCT01289301 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT01289301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01289301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polyomavirus BK Nephropathy After Renal Transplantation: Randomized Clinical Trial to Demonstrate That Switching to mTOR Inhibitor is More Effective Than a Reduction of Immunosuppressive Therapy
Lead sponsor
Hannover Medical School
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2011
Completion date
October 31, 2018
Enrollment
124 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to renal transplantation, immunosuppression related infectious disease, virus diseases